Added Title

DLSU AKI Policy Brief, Volume XIII No. 1

Document Type

Policy Brief

Publication Date

3-2020

Place of Publication

DLSU-Angelo King Institute, Room 223, LS building, 2401 Taft Avenue, Manila 0922

Abstract

Drugs for the treatment of Covid-19 are currently beign tested, and those that are apporved for use are likely to be in short supply due to the global scale of the pandemic. This policy brief proposes a model for optimally allocating future Covid-19 drugs to patients to minimize deaths under conditions of resource scarcity. A linear programming model is developed that estimates the potential number of deaths that may result from Covid-19 under two scenarios: with antivirals and without antivirals. It takes into account patient risk level, the severity of their symptoms, resource availability in hospitals (i.e. hospital beds, critical care units, ventilators), observed mortality rates, and share of the Philippine population. Based on simulations, the model can make actionable recommendations on how to prioritize the allocation of the drugs.

html

Disciplines

Chemicals and Drugs | Community Health and Preventive Medicine | Public Health Education and Promotion

Keywords

Medicine; Covid-19; pandemic; drugs; Philippines

Upload File

wf_yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.